
Sign up to save your podcasts
Or
Shadd Dales takes a closer look at the growing tension between MediPharm Labs (TSX: LABS) and one of its largest independent shareholders, Apollo Technology Capital Corporation.Apollo, which holds nearly 3% of MediPharm’s shares, is pushing for major change after the company posted its 21st consecutive quarterly loss. With only $8.4 million in cash and over $3.3 million burned in Q1 alone, Apollo believes the company could run out of money by November 2025. They’re also pointing to declining revenues, especially in international and Canadian adult-use markets, and what they see as a lack of a realistic turnaround plan.In response, Apollo has proposed replacing the current board with six new nominees, including cannabis and capital markets professionals. Their “5-Pillar Plan” focuses on restoring financial discipline, improving transparency, and protecting shareholder value.MediPharm has pushed back, questioning the dissident group’s approach and filing concerns over procedural issues. With the June 13 vote approaching, shareholders will soon decide whether change is needed—or whether to stay the course.This episode is an important listen for anyone following cannabis stocks, board governance, and the state of Canadian cannabis companies.#CannabisInvesting #MediPharmLabs #ApolloCapital #CannabisStocks #TSXLABS #CannabisIndustry #ShareholderRights #BoardGovernance #CannabisFinance #CannabisReform0:00:00 Intro0:02:53 MediPharm Labs' financial struggles0:03:22 Executive compensation details0:04:34 Cash burn and financial situation0:06:46 Board's refusal to engage with Apollo Capital0:07:30 Shareholder leverage and frustrations0:10:16 Execution missteps in the company0:13:06 Canna Farms facility sale discussion0:16:32 Pharmaceutical vs. medical cannabis business challenges0:19:30 International market strategy issues0:22:55 Apollo Capital's five-pillar plan0:37:26 Future opportunities beyond MediPharm0:45:01 Texas hemp Market0:46:20 Shareholder voting scheduleWant to see last week's recap? • Texas Hemp Ban, SAFE Banking Turmoil ... Want to see more Cannabis Reform videos? • How the Government is holding back th... • Senator Tillis Pushes Back on Trump’s... • What Trump Could Announce in US-Canad... • Trump’s DEA Nominee Holds Back on Mar... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...
5
77 ratings
Shadd Dales takes a closer look at the growing tension between MediPharm Labs (TSX: LABS) and one of its largest independent shareholders, Apollo Technology Capital Corporation.Apollo, which holds nearly 3% of MediPharm’s shares, is pushing for major change after the company posted its 21st consecutive quarterly loss. With only $8.4 million in cash and over $3.3 million burned in Q1 alone, Apollo believes the company could run out of money by November 2025. They’re also pointing to declining revenues, especially in international and Canadian adult-use markets, and what they see as a lack of a realistic turnaround plan.In response, Apollo has proposed replacing the current board with six new nominees, including cannabis and capital markets professionals. Their “5-Pillar Plan” focuses on restoring financial discipline, improving transparency, and protecting shareholder value.MediPharm has pushed back, questioning the dissident group’s approach and filing concerns over procedural issues. With the June 13 vote approaching, shareholders will soon decide whether change is needed—or whether to stay the course.This episode is an important listen for anyone following cannabis stocks, board governance, and the state of Canadian cannabis companies.#CannabisInvesting #MediPharmLabs #ApolloCapital #CannabisStocks #TSXLABS #CannabisIndustry #ShareholderRights #BoardGovernance #CannabisFinance #CannabisReform0:00:00 Intro0:02:53 MediPharm Labs' financial struggles0:03:22 Executive compensation details0:04:34 Cash burn and financial situation0:06:46 Board's refusal to engage with Apollo Capital0:07:30 Shareholder leverage and frustrations0:10:16 Execution missteps in the company0:13:06 Canna Farms facility sale discussion0:16:32 Pharmaceutical vs. medical cannabis business challenges0:19:30 International market strategy issues0:22:55 Apollo Capital's five-pillar plan0:37:26 Future opportunities beyond MediPharm0:45:01 Texas hemp Market0:46:20 Shareholder voting scheduleWant to see last week's recap? • Texas Hemp Ban, SAFE Banking Turmoil ... Want to see more Cannabis Reform videos? • How the Government is holding back th... • Senator Tillis Pushes Back on Trump’s... • What Trump Could Announce in US-Canad... • Trump’s DEA Nominee Holds Back on Mar... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...
39 Listeners
3,685 Listeners
93 Listeners
1,839 Listeners
205 Listeners
67 Listeners
5,244 Listeners
406 Listeners
104 Listeners
28,354 Listeners
8,543 Listeners
119 Listeners
7 Listeners
12 Listeners
958 Listeners